546-88-3

  • Product Name:Acetohydroxamic acid
  • Molecular Formula:C2H5NO2
  • Purity:99%
  • Molecular Weight:75.0672
Inquiry

Product Details

Reputable factory supply Acetohydroxamic acid 546-88-3 in bulk at low price

  • Molecular Formula:C2H5NO2
  • Molecular Weight:75.0672
  • Appearance/Colour:White crystalline solid 
  • Vapor Pressure:0.0118mmHg at 25°C 
  • Melting Point:88-90 °C(lit.) 
  • Refractive Index:1.42 
  • Boiling Point:231.4 °C at 760 mmHg 
  • PKA:8.70(at 25℃) 
  • Flash Point:127.6 °C 
  • PSA:49.33000 
  • Density:1.155 g/cm3 
  • LogP:-0.09740 

Acetohydroxamic acid(Cas 546-88-3) Usage

Manufacturing Process

3 Methods of producing of acetohydroxamic acid: 1. Ethyl acetic acid ether was treated with hydroxylamine and acetohydroxamic acid was obtained. 2. Acetohydroxamic acid was obtained in the result of reaction of acetamide with hydroxylamine. 3. Acetohydroxamic acid was obtained by treatment of acetaldehyde with nitrohydroxylamine.

Therapeutic Function

Urease inhibitor

Side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.Call your doctor at once if you have:pounding heartbeats or fluttering in your chest;signs of a blood clot in your leg --pain, swelling, warmth, or redness in one or both legs;signs of a red blood cell disorder --pale or yellowed skin, dark colored urine, fever, confusion or weakness.Common side effects may include:headache during the first 2 days of treatment;skin rash, warmth, tingling or redness (especially if you drink alcohol while taking acetohydroxamic acid);upset stomach, nausea, loss of appetite;depressed mood;anxiety, tremors, nervousness;hair loss.

Safety Profile

Moderately toxic by intraperitonealroute. An experimental teratogen. Other experimentalreproductive effects. Mutation data reported. When heatedto decomposition it emits toxic fumes of NOx.

Veterinary Drugs and Treatments

Acetohydroxamic acid can be used in dogs as adjunctive therapy in some cases of recurrent urolithiasis or in the treatment of persistent urinary tract infections caused by the following bacteria: E. coli, Klebsiella, Morganella morganii, Staphylococci spp., and Pseudomonas aeruginosa. Adverse effects limit its usefulness.

Brand name

Lithostat (Mission).

General Description

Acetohydroxamic acid is a potent inhibitor of bacterial urease activity and reduces urinary ammonia levels. 2-Acetohydroxamic acid loaded floating microspheres forms an efficient drug delivery system for the treatment of Helicobacter pylori.

InChI:InChI=1/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4)

546-88-3 Relevant articles

N-O Bond Fission as the Rate-Determining Step in the Aqueous Conversion of N-Peptidyl-O-(p-nitrobenzoyl)hydroxylamines to p-Nitrobenzoic Acid and Peptidylhydroxamic Acids

Demuth, Hans-Ulrich,Fischer, G.,Barth, A.,Schowen, R. L.

, p. 5880 - 5883 (1989)

N-Acetyl-, N-alanyl-alanyl-, N-alanyl-pr...

Investigation of structural effects and behaviour of Pseudomonas aeruginosa amidase encapsulated in reversed micelles

Fragoso, Ana,Pacheco, Rita,Karmali, Amin

, p. 264 - 272 (2012)

The acetohydroxamic acid synthesis react...

Activation and Orientation by Receptor-Substrate Binding. The Case of Acyl Transfer from O-Acetylhydroxylamine

Lehn, Jean-Marie,Nishiya, Takako

, p. 215 - 218 (1987)

The strong binding ability of the recept...

The reaction of hydroxamic acids with water-soluble carbodiimides. A Lossen rearrangement.

Hoare,Olson,Koshland Jr.

, p. 1638 - 1643 (1968)

-

Hydroxamic acids. II. Kinetics and mechanisms of hydroxyaminolysis of succinimide.

Notari

, p. 1064 - 1068 (1969)

-

Alternating Current Electrolysis as Efficient Tool for the Direct Electrochemical Oxidation of Hydroxamic Acids for Acyl Nitroso Diels–Alder Reactions

F?hrmann, Jan,Hilt, Gerhard

supporting information, p. 20313 - 20317 (2021/08/12)

The acyl nitroso Diels–Alder reaction of...

Hydroxamates as a potent skeleton for the development of metallo-β-lactamase inhibitors

Chen, Cheng,Chigan, Jia-Zhu,Ding, Huan-Huan,Li, Jia-Qi,Liu, Lu,Xu, Yin-Sui,Yang, Ke-Wu

, (2021/12/14)

Bacterial resistance caused by metallo-β...

Novel fluorinated 7-hydroxycoumarin derivatives containing an oxime ether moiety: Design, synthesis, crystal structure and biological evaluation

Dai, Peng,Jiao, Jian,Wang, Qing-Qing,Zhang, Shu-Guang,Zhang, Wei-Hua

, (2021/06/28)

A series of fluorinated 7-hydroxycoumari...

Synthetic method for acetylhydroxylamine

-

Paragraph 0026-0029, (2021/08/06)

The invention provides a synthesis metho...

546-88-3 Process route

water
7732-18-5

water

hydroxylamine
7803-49-8

hydroxylamine

adenosine-5'-phosphoric acetic anhydride
13015-87-7

adenosine-5'-phosphoric acetic anhydride

acetylhydroxamic acid
546-88-3

acetylhydroxamic acid

5'-adenosine monophosphate
61-19-8,24937-83-5,67583-85-1

5'-adenosine monophosphate

Conditions
Conditions Yield
at 37 ℃; pH 6; Halbwertszeit der Reaktion;
<i>N</i>-(1-nitroso-ethylidene)-hydroxylamine
3354-65-2

N-(1-nitroso-ethylidene)-hydroxylamine

acetic acid
64-19-7,77671-22-8

acetic acid

acetylhydroxamic acid
546-88-3

acetylhydroxamic acid

cis-nitrous acid
7782-77-6

cis-nitrous acid

Conditions
Conditions Yield

546-88-3 Upstream products

  • 60-35-5
    60-35-5

    acetamide

  • 463-51-4
    463-51-4

    Ketene

  • 107-29-9
    107-29-9

    Acetaldehyde oxime

  • 79-24-3
    79-24-3

    Nitroethane

546-88-3 Downstream products

  • 76412-58-3
    76412-58-3

    N-acetyl-O-benzoylhydroxylamine

  • 70341-55-8
    70341-55-8

    12-(3-hydroxy-octa-4,6-dienoyl)-9,10-dimethyl-9,10-dihydro-10,9-oxaazaethano-anthracene

  • 51029-28-8
    51029-28-8

    12-acetyl-9,10-dimethyl-9,10-dihydro-10,9-oxaazaethano-anthracene

  • 95705-96-7
    95705-96-7

    Acetamino-(1,3,5-tri-tert-butyl-4-oxo-cyclohexa-2,5-dienyl)-ether

Relevant Products